Yoshihiko Hatanaka
Yoshihiko Hatanaka (shelf or Yoshihiko, April 20, 1957 -) is a Japanese businessman. Astellas Pharma Inc.'s president.
Person
Shizuoka birth. I graduate from Hitotsubashi University department of economics in 1980, and, via Shizuoka Prefectural Shizuoka high school, it is entered the company by Fujisawa Pharmaceutical. After having experienced a medical representative in Osaka, through management plan director or アステラスファーマ US's president, I take office as Astellas Pharma Inc.'s president in 2011.
Across Takeda Pharmaceutical Co., Ltd. of the industry first place having never met you with net income by mergers and acquisitions for March, 2015 period [1]. In addition, in running out of patent of the main product, I developed the new medicine by the investment to the cancer domain, and "Ickx Tanji" who started sale from 2012 achieved yearly turnover 100 billion yen by 2015 [2]. Received executive compensation of 218 million yen for executive compensation of 214 million yen for executive compensation of 143 million yen each in 2014 in 2013 in 2012 [3]; [4].
Career
- I am from Shizuoka for 1,957 years
- 1980 Hitotsubashi University department of economics graduation, Fujisawa Pharmaceutical entering a company
- 2003 Fujisawa Pharmaceutical management plan director
- 2005 Astellas Pharma Inc. management plan director
- 2011 Astellas Pharma Inc.'s president-director
Footnote
- ^ For "ass terrace merger ten years, I surpass Takeda in profit and pass, and field sorting works"Nihon Keizai Shimbun 2015/2/3
- ^ weekly publication Orient economy September 3, 2011 issue
- ^ "list of 443 listed company officers Orient economy online March 18, 2015 of "more than" yearly income 100 million yen"
- ^ "response Orient economy online March 27, 2015 that I got in Astellas Pharma Inc., merger ten years"
This article is taken from the Japanese Wikipedia Yoshihiko Hatanaka
This article is distributed by cc-by-sa or GFDL license in accordance with the provisions of Wikipedia.
In addition, Tranpedia is simply not responsible for any show is only by translating the writings of foreign licenses that are compatible with CC-BY-SA license information.
0 개의 댓글:
댓글 쓰기